Phase III Randomised, Double Blind, Placebo Controlled Study of Olaparib Maintenence Monotherapy in Platinum Sensitive relapsed BRCA Mutated Ovarian Cancer Patients With a Complete or Partial Response Following Platinum Based Chemotherapy
Trial Number
NCT01874353 (ClinicalTrials.gov ID)Contact Person
Status
Completed
Disease Site
Recurrent Ovarian
Lead Cooperative Group
Participating Groups
AGO
MITO
AGO-AUST
BGOG